Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer's disease

Akiyama, 2000, Inflammation and Alzheimer's disease, Neurobiol. Aging, 21, 383, 10.1016/S0197-4580(00)00124-X

Anantharamaiah, 2007, Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides, J. Lipid Res., 48, 1915, 10.1194/jlr.R700010-JLR200

Barter, 2006, Relationship between the concentration and anti-atherogenic activity of high-density lipoproteins, Curr. Opin. Lipidol., 17, 399, 10.1097/01.mol.0000236365.40969.af

Bloedon, 2008, Safety, pharmacokinetics, and pharmacodynamics of oral apo A-I mimetic peptide D-4F in high-risk cardiovascular patients, J Lipid Res., 49, 1344, 10.1194/jlr.P800003-JLR200

Boche, 2008, The role of immune system in clearance of Aβ from the brain, Brain Pathol., 18, 267, 10.1111/j.1750-3639.2008.00134.x

Buga, 2006, D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet, J. Lipid Res., 47, 2148, 10.1194/jlr.M600214-JLR200

Burgess, 2006, Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer's disease mouse models with abundant A beta in plasma, Neurobiol. Dis., 24, 114, 10.1016/j.nbd.2006.06.007

Cao, 2007, Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer's disease, J. Bio. Chem., 282, 36275, 10.1074/jbc.M703561200

Chauhan, 2004, Effects of lovastatin and pravastatin on amyloid processing and inflammatory response in TgCRND8 brain, Neurochem. Res., 29, 1897, 10.1023/B:NERE.0000042217.90204.8d

Christen, 2000, Oxidative stress and Alzheimer's disease, Am. J. Clin. Nutr., 71, 621s, 10.1093/ajcn/71.2.621s

Coraci, 2002, CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils, Am. J. Pathol., 160, 101, 10.1016/S0002-9440(10)64354-4

Datta, 2004, Aromatic residue position on the nonpolar face of class A amphipathic helical peptides determines biological activity, J. Biol. Chem., 279, 26509, 10.1074/jbc.M314276200

Dickson, 1999, Microglia in Alzheimer's disease and transgenic models. How close the fit?, Am. J. Pathol., 154, 1627, 10.1016/S0002-9440(10)65416-8

Gupta, 2005, Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein A-I mimetic peptide, Circ. Res., 97, 236, 10.1161/01.RES.0000176530.66400.48

Hebert, 2003, Alzheimer's disease in the US population: prevalence estimates using the 2000 census, Arch. Neurol., 60, 1119, 10.1001/archneur.60.8.1119

Heneka, M.T., Sastre, M., Dumitrescu-Ozimek, L., Hanke, A., Dewachter, I., Kuiperi, C., O'Bannion, K., Klockgether, T., Van Leuven, F., Landreth, G., 2005. Acute treatment with the PPARg agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta 1–42 levels in APPV717I transgenic mice. Brain 128, 1442–1453.

Hickman, 2008, Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice, J. Neurosci., 28, 8354, 10.1523/JNEUROSCI.0616-08.2008

In t' Veld, 2001, Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease, N. Engl. J. Med., 345, 1515, 10.1056/NEJMoa010178

Irizarry, 1997, APPswe transgenic mice develop age-related A beta deposits and neutrophile abnormalities, but no neuronal loss in CA1, J. Neuropathol. Exp. Neurol., 56, 965, 10.1097/00005072-199709000-00002

Ishizuka, 1997, Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease, Psychiatry Clin. Neurosci., 51, 135, 10.1111/j.1440-1819.1997.tb02375.x

Jankowsky, 2004, Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific g secretase, Hum. Mol. Genet., 13, 159, 10.1093/hmg/ddh019

Kim, 2006, Microglia, major player in the brain inflammation: their roles in pathogenesis of Parkinson's disease, Exp. Mol. Med., 38, 333, 10.1038/emm.2006.40

Kunjathoor, 2004, Beta- amyloid promotes accumulation of lipid peroxides by inhibiting CD36 mediated clearance of oxidized lipoproteins, J. Neuroinflammation, 1, 23, 10.1186/1742-2094-1-23

Li, 2003, Association of aortic atherosclerosis with cerebral beta amyloidosis and learning defects in a mouse model of Alzheimer's disease, Am. J. Pathol., 163, 2155, 10.1016/S0002-9440(10)63572-9

McGeer, 2003, Inflammatory processes in Alzheimer's disease. 2003, Prog. Neuropsychopharmacol. Biol. Psychiatry, 27, 741, 10.1016/S0278-5846(03)00124-6

McGeer, 1987, Reactive microglia in patints with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR, Neurosci. Lett., 79, 195, 10.1016/0304-3940(87)90696-3

Murray, 1998, Evidence that increased hippocampal expression of the cytokine interleukin 1beta is a common trigger for age- and stress induced impairments in long-term potentiations, J. Neurosci., 18, 2974, 10.1523/JNEUROSCI.18-08-02974.1998

Navab, 2002, Oral administration of an apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol, Circulation, 105, 290, 10.1161/hc0302.103711

Navab, 2005, The role of high-density lipoprotein in inflammation, Trends Cardiovasc. Med., 15, 158, 10.1016/j.tcm.2005.05.008

Navab, 2005, D-4F and statins synergize to render HDL anti-inflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice, Arterioscler. Thromb. Vasc. Biol., 25, 1426, 10.1161/01.ATV.0000167412.98221.1a

Pratico, 2000, Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease, Am. J. Med., 109, 577, 10.1016/S0002-9343(00)00547-7

Ransohoff, 1993, Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis, FASEB J., 7, 592, 10.1096/fasebj.7.6.8472896

Refolo, 2000, Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model, Neurobiol. Dis., 7, 321, 10.1006/nbdi.2000.0304

Sedgwick, 2000, Tumor necrosis factor: a master-regulator of leukocyte movement, Immunol. Today, 21, 110, 10.1016/S0167-5699(99)01573-X

Segrest, J.P., Jones, M.K., De Loof, H., Brouillette, C.G., Venkatachalapathi, Y.V., Anantharamaiah, G.M., 1992. The amphipathic helix in exchangeable apolipoproteins: a review of secondary structure and function. J. Lipid Res. 33, 141–166.

Shankar, 2008, Amyloid-β protein dimmers isolated directly from Alzheimer's brain impair synaptic plasticity and memory, Nat. Med., 14, 837, 10.1038/nm1782

Sokolova, 2008, Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's disease, Brain Pathol.

Ubogu, 2006, The expression and function of chemokines involved in CNS inflammation, Trends Pharmacol. Sci., 27, 48, 10.1016/j.tips.2005.11.002

Van Lenten, 2008, Anti-inflammatory apo A-I mimetic peptides bind oxidized lipids with much higher affinity than human apo A-I, J. Lipid Res., 49, 2302, 10.1194/jlr.M800075-JLR200

Vassar, 1999, Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE, Science, 286, 735, 10.1126/science.286.5440.735

Weihrauch, 2007, Effects of D-4F on vasodilation, oxidative stress, angiostatin, myocardial inflammation, and angiogenic potential in tight-skin mice. 2007, Am. J. Physiol. Heart Circ. Physiol., 293, H1432, 10.1152/ajpheart.00038.2007

Yates, 2000, Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokines production by THP-1 cells and murine microglia, J. Neurochem., 74, 1017, 10.1046/j.1471-4159.2000.0741017.x

Zandi, 2002, Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study, Neurology, 59, 880, 10.1212/WNL.59.6.880